Literature DB >> 9718579

Filamentous bacteriophage display of a bifunctional protein A::scFv fusion.

Y Li1, W Cockburn, G C Whitelam.   

Abstract

Filamentous bacteriophage display is a powerful and widely used technology for the selection of affinity ligands. However, the commonly used phagemid systems result in the production of a population of phage of which those displaying the ligand of interest represent only a small proportion. Through simple dilution and nonspecific binding effects, the presence of large numbers of ligand-free phage reduces the likelihood that weak binders will be successfully selected from a ligand library. To provide a means of avoiding such problems, we have introduced an affinity handle into the phage that permits the purification of ligand-displaying phage. The IgG binding domains of Staphylococcus aureus protein A (SpA) were fused to a ligand (single chain Fv[scFv]) which is displayed as a fusion with the phage surface protein delta pIII. Phage-displaying SpA were separated by affinity chromatography using immobilized human IgG from non-displaying phage and the purified phage were shown to possess functional scFv. Comparisons of fusion proteins in which either the scFv or the affinity handle occupied the amino terminus of the fusion protein showed that, whereas SpA function was unaffected by position, scFv function was compromised when the scFv did not occupy the amino terminus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718579     DOI: 10.1007/bf02915792

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  16 in total

1.  A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv.

Authors:  M S Tai; M Mudgett-Hunter; D Levinson; G M Wu; E Haber; H Oppermann; J S Huston
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

2.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

Authors:  C F Barbas; A S Kang; R A Lerner; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Fusions to staphylococcal protein A.

Authors:  B Nilsson; L Abrahmsén
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies.

Authors:  D J Panka; M Mudgett-Hunter; D R Parks; L L Peterson; L A Herzenberg; E Haber; M N Margolies
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Construction and characterization of M13 bacteriophages displaying functional IgG-binding domains of staphylococcal protein A.

Authors:  A Kushwaha; P S Chowdhury; K Arora; S Abrol; V K Chaudhary
Journal:  Gene       Date:  1994-12-30       Impact factor: 3.688

Review 6.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Bacteriophage surface display of an immunoglobulin-binding domain of Staphylococcus aureus protein A.

Authors:  B M Djojonegoro; M J Benedik; R C Willson
Journal:  Biotechnology (N Y)       Date:  1994-02

8.  Production and secretion of a bifunctional staphylococcal protein A::antiphytochrome single-chain Fv fusion protein in Escherichia coli.

Authors:  A R Gandecha; M R Owen; B Cockburn; G C Whitelam
Journal:  Gene       Date:  1992-12-15       Impact factor: 3.688

9.  Rapid assay of phage-derived recombinant human fabs as bispecific antibodies.

Authors:  P P Sanna; A De Logu; R A Williamson; M E Samson; D C Altieri; F E Bloom; D R Burton
Journal:  Biotechnology (N Y)       Date:  1995-11

10.  Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors.

Authors:  B Nilsson; L Abrahmsén; M Uhlén
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

View more
  1 in total

1.  Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A.

Authors:  Stefan Werner; Sylvestre Marillonnet; Gerd Hause; Victor Klimyuk; Yuri Gleba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.